18 окт. 2024 г. · This page includes a chart of the approved biosimilar and interchangeable products. The approval of biosimilar products can improve access ...

17 окт. 2024 г. · There are currently 62 biosimilars approved by the US Food and Drug Administration (FDA). The most recent biosimilar approval was Imuldosa (ustekinumab-srlf) ...

To date, FDA has approved 56 biosimilars within the product classes of: 1) insulin; 2) granulocyte colony-stimulating factor; 3) monoclonal antibodies and 4) ...

The Food and Drug Administration (FDA) has approved 53 biosimilars. Below are lists of all approved biosimilars divided into those that are on the market and ...

To date, EMA has recommended the approval of 106 biosimilars within the product classes of: 1) human growth hormone; 2) granulocyte colony-stimulating factor; ...

14 авг. 2024 г. · Biosimilars used in cancer treatment · Mvasi · Zirabev · Alymsys · Vegzelma · Avzivi. Biosimilars for the biologic medicine rituximab (Rituxan):.

This page was last updated November 18, 2024. Current Region Flag. United States. Total Approved: 61. Total Launched: 41. Select Nonproprietary Drug Name:.

The FDA maintains a list of approved biologics cataloged by year and archived back to 2014 here.

Оценка 4,5 (4 326) 8 мая 2024 г. · List of FDA approved biosimilars ; Simlandi (adalimumab-ryvk), February 2024, Humira (adalimumab) ; Avzivi (bevacizumab-tnjn), December 2023 ...

20 сент. 2021 г. · List of all FDA-approved biosimilars in the U.S., with date approved, made available and the biologic they reference.